SCHEMBL7994247

SCHEMBL7994247

Cn1c(C2CC2)nc(-c2ccc(C#N)c(Cl)c2)c1Sc1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CNR1 P21554 3/20 0.38
CNR2 P34972 3/20 0.38
ALDH1A1 P00352 5/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 4/20 0.35
CYP2C19 P33261 4/20 0.35
CYP2C9 P11712 3/20 0.35
CYP3A4 P08684 3/20 0.35
PGR P06401 1/20 0.35
KDM1A O60341 1/20 0.35
CYP2D6 P10635 2/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8005184 0.77 FAAH (0.61) FAAHMAOAMAOBCNR1CNR2
SCHEMBL1302181 0.72 FAAH (0.48) FAAH
SCHEMBL12105938 0.72 FAAH (0.48) FAAH
SCHEMBL1303552 0.71 FAAH (0.48) FAAH
SCHEMBL1431539 0.70 FAAH (0.41) FAAHCNR1MAPT
SCHEMBL1304002 0.70 FAAH (0.48) FAAH
SCHEMBL1303791 0.67 MAOA (0.50) FAAHMAOAMAOBCNR1CNR2
SCHEMBL8006327 0.66 GAA (0.52) FAAHMAOAMAOBALDH1A1MEN1
SCHEMBL1302719 0.65 FAAH (0.50) FAAHMAOAMAOBALDH1A1HPGD
SCHEMBL1302358 0.64 FAAH (0.43) FAAHMAOAMAOBALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885MAOA 61/4885MAOB 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.